References
- Eliakim-Raz N, Prokupetz A, Gordon B, Shochat T, Grossman A. Interventricular septum and posterior wall thickness are associated with higher systolic blood pressure. J Clin Hypertens. 2016 Jul;18(7):703–06. doi:https://doi.org/10.1111/jch.12738.
- Zhi-Bin H, Chang F, Mao-Huan L, Gui-Yi Y, Shu-Xian Z, Wei W. Valsartan improves the electrophysiological characteristics of left ventricular hypertrophic myocardium in spontaneously hypertensive rats. Hypertens Res. 2014 Sep;37(9):824–29. doi:https://doi.org/10.1038/hr.2014.85.
- Zhang J-Q, Yang G-H, Zhou X, Liu J-X, Shi R, Dong Y, Chen S-B, Li Y-M, Effects of allisartan isoproxil on blood pressure and target organ injury in patients with mild to moderate essential hypertension. Medicine. 2019 Mar;98(12):e14907. doi:https://doi.org/10.1097/MD.0000000000014907.
- Wu M, Ma X, Yang C, Tao X, Liu A, Su D, Liu J-G, Effects of allisartan, a new AT1 receptor blocker, on blood pressure and end-organ damage in hypertensive animals. Acta Pharmacol Sin. 2009 Mar;30(3):307–13. doi:https://doi.org/10.1038/aps.2009.11.
- Liu Y, Wang H, Cheng Y, Sun J, Qiao J, Lu H, Zhu L, Gong L, Ren J, A 26-week repeated-dose toxicity study of allisartan isoproxil in Sprague-Dawley rats. Drug Chem Toxicol. 2013 Oct;36(4):443–50. doi:https://doi.org/10.3109/01480545.2013.776580.
- Zhang H, Wu S, Huang C, Li X. Long-term treatment of spontaneously hypertensive rats with losartan and molecular basis of modulating Ito of ventricular myocytes. Mol Med Rep. 2014 May;9(5):1959–67. doi:https://doi.org/10.3892/mmr.2014.2001.
- Cuspidi C. Angiotensin II receptor blockers and cardiovascular protection: focus on left ventricular hypertrophy regression and atrial fibrillation prevention. VHRM. 2008 Feb;4:67–73. doi:https://doi.org/10.2147/VHRM.S1899.
- Shibasaki Y, Masaki H, Nishiue T, Nishikawa M, Matsubara H, Iwasaka T. Angiotensin II Type 1 receptor antagonist, losartan, causes regression of left ventricular hypertrophy in end-stage renal disease. Nephron. 2002;90(3):256–61.doi:https://doi.org/10.1159/000049060.
- Obayashi M, Yano M, Kohno M, Kobayashi S, Tanigawa T, Hironaka K, Ryouke T, Matsuzaki M, Dose-dependent effect of ANG II-receptor antagonist on myocyte remodeling in rat cardiac hypertrophy. Am J Physiol Heart Circ Physiol. 1997 Oct 1;273(4):H1824–31. https://doi.org/10.1152/ajpheart.1997.273.4.H1824.
- Kjeldsen SE, Strand A, Julius S, Okin PM. Mechanism of Angiotensin II Type 1 Receptor Blocker Action in the Regression of Left Ventricular Hypertrophy. J Clin Hypertension. 2006 Jul;8(7):487–92. doi:https://doi.org/10.1111/j.1524-6175.2006.05366.x.
- Suzuki H, Nakamoto H, Okada H, Sugahara S, Kanno Y. A selective angiotensin receptor antagonist, Valsartan, produced regression of left ventricular hypertrophy associated with a reduction of arterial stiffness. Adv Perit Dial. 2003;19:59–66.
- Tsunoda K, Abe K, Hagino T, Omata K, Misawa S, Imai Y, Yoshinaga, K, Hypotensive Effect of Losartan, a Nonpeptide Angiotensin II Receptor Antagonist, in Essential Hypertension. Am J Hypertens. 1993 Jan;6(1):28–32. doi:https://doi.org/10.1093/ajh/6.1.28.
- Sica DA, Gehr TWB, Ghosh S. Clinical Pharmacokinetics of Losartan. Clin Pharmacokinet. 2005;44(8):797–814.doi:https://doi.org/10.2165/00003088-200544080-00003.
- Amini H, Ahmadiani A, Moazenzadeh M. Pharmacokinetics of Losartan and its Active Metabolite EXP3174 in Healthy Iranian Subjects. Clin Drug Investig. 2004;24(10):619–23.doi:https://doi.org/10.2165/00044011-200424100-00008.
- Schirone L, Forte M, Palmerio S, Yee D, Nocella C, Angelini F, Pagano F, Schiavon S, Bordin A, Carrizzo A, et al. A review of the molecular mechanisms underlying the development and progression of cardiac remodeling. Oxid Med Cell Longev. 2017;2017:1–16.
- Bachmann M, Li W, Edwards MJ, Ahmad SA, Patel S, Szabo I, Gulbins E, Voltage-gated potassium channels as regulators of cell death. Front Cell Dev Biol. 2020 Dec 14;8:611853. https://doi.org/10.3389/fcell.2020.611853.
- Ohanyan V, Yin L, Bardakjian R, Kolz C, Enrick M, Hakobyan T, Kmetz J, Bratz I, Luli J, Nagane M, et al. Requisite Role of Kv1.5 channels in coronary metabolic dilation. Circ Res. 2015 Sep 11;117(7):612–21. https://doi.org/10.1161/CIRCRESAHA.115.306642.
- Lee J-K, Nishiyama A, Kambe F, Seo H, Takeuchi S, Kamiya K, Kodama I, Toyama J, Downregulation of voltage-gated K + channels in rat heart with right ventricular hypertrophy. Am J Physiol Heart Circ Physiol. 1999 Nov1;277(5):H1725–31. https://doi.org/10.1152/ajpheart.1999.277.5.H1725.
- Grandi E, Sanguinetti MC, Bartos DC, Bers DM, Chen-Izu Y, Chiamvimonvat N, Colecraft HM, Delisle BP, Heijman J, Navedo MF, et al., Potassium channels in the heart: structure, function and regulation. J Physiol. 2017 01;595(7):2209–28. doi:https://doi.org/10.1113/JP272864.
- Kaur S, Muthuraman A. Therapeutic evaluation of rutin in two-kidney one-clip model of renovascular hypertension in rat. Life Sci. 2016 Apr;150:89–94. doi:https://doi.org/10.1016/j.lfs.2016.02.080.
- Anderson WP, Kett MM, Stevenson KM, Edgley AJ, Denton KM, Fitzgerald SM. Renovascular Hypertension: structural changes in the renal vasculature. Hypertension. 2000 Oct;36(4):648–52. doi:https://doi.org/10.1161/01.HYP.36.4.648.
- Hedegaard ER, Nielsen BD, Kun A, Hughes AD, Krøigaard C, Mogensen S, Matchkov VV, Fröbert O, Simonsen U, KV 7 channels are involved in hypoxia-induced vasodilatation of porcine coronary arteries. Br J Pharmacol. 2014 Jan;171(1):69–82. doi:https://doi.org/10.1111/bph.12424.
- Li Y, Li X, Huang Z, Yang G, Zhang G, Zhao S, Guo Y, Lu S-J, Ma J-L, Meng F-B, et al. A randomized, double blind, placebo-controlled, multicenter phase II trial of Allisartan Isoproxil in essential hypertensive population at low-medium risk. PLoS ONE. 2015;10(2):e0117560. doi:https://doi.org/10.1371/journal.pone.0117560.
- Aronow WS. Hypertension and left ventricular hypertrophy. Ann Transl Med. 2017 Aug;5(15):310–310. doi:https://doi.org/10.21037/atm.2017.06.14.
- Kahan T. Left ventricular hypertrophy in hypertension: its arrhythmogenic potential. Heart. 2005 Feb 1;91(2):250–56. https://doi.org/10.1136/hrt.2004.042473.
- He D-H, Zhang L-M, Lin L-M, Ning R-B, Wang H-J, Xu C-S, Lin J-X, Effects of Losartan and Amlodipine on Left Ventricular Remodeling and Function in Young Stroke-Prone Spontaneously Hypertensive Rats. Acta Cardiol Sin. 2014 Jul;30(4):316–24.
- Zornoff LAM, Matsubara LS, Matsubara BB, Paiva SAR, Spadaro J. Effects of losartan on ventricular remodeling in experimental infarction in rats. Arq Bras Cardiol [Internet]. 2000 Dec [cited 2020 Aug 5];75(6):(6). DOI:https://doi.org/10.1590/S0066-782X2000001200001.
- Nattel S, Maguy A, Le Bouter S, Yeh Y-H. Arrhythmogenic Ion-Channel Remodeling in the Heart: heart Failure, Myocardial Infarction, and Atrial Fibrillation. Physiol Rev. 2007 Apr;87(2):425–56. doi:https://doi.org/10.1152/physrev.00014.2006.
- Aronson RS. Characteristics of action potentials of hypertrophied myocardium from rats with renal hypertension. Circ Res. 1980 Sep;47(3):443–54. doi:https://doi.org/10.1161/01.RES.47.3.443.
- Gidh-Jain M, Huang B, Jain P, El-Sherif N. Differential Expression of Voltage-Gated K + Channel Genes in Left Ventricular Remodeled Myocardium After Experimental Myocardial Infarction. Circ Res. 1996 Oct;79(4):669–75. doi:https://doi.org/10.1161/01.RES.79.4.669.
- Marionneau C, Brunet S, Flagg TP, Pilgram TK, Demolombe S, Nerbonne JM. Distinct Cellular and Molecular Mechanisms Underlie Functional Remodeling of Repolarizing K + currents with left ventricular hypertrophy. Circ Res. 2008 Jun 6;102(11):1406–15. https://doi.org/10.1161/CIRCRESAHA.107.170050.
- Matsubara H, Suzuki J, Inada M. Shaker-related potassium channel, Kv1.4, mRNA regulation in cultured rat heart myocytes and differential expression of Kv1.4 and Kv1.5 genes in myocardial development and hypertrophy. J Clin Invest. 1993 Oct 1;92(4):1659–66. https://doi.org/10.1172/JCI116751.
- Xu H, Dixon JE, Barry DM, Trimmer JS, Merlie JP, McKinnon D, Nerbonne JM, Developmental analysis reveals mismatches in the expression of K+ channel alpha subunits and voltage-gated K+ channel currents in rat ventricular myocytes. J Gen Physiol. 1996 Nov;108(5):405–19. doi:https://doi.org/10.1085/jgp.108.5.405.
- Guo W, Kamiya K, Kada K, Kodama I, Toyama J. Regulation of Cardiac Kv1.5 K+Channel expression by cardiac fibroblasts and mechanical load in cultured newborn rat ventricular myocytes. J Mol Cell Cardiol. 1998 Jan;30(1):157–66. doi:https://doi.org/10.1006/jmcc.1997.0584.